JP2023530166A5 - - Google Patents
Info
- Publication number
- JP2023530166A5 JP2023530166A5 JP2022577618A JP2022577618A JP2023530166A5 JP 2023530166 A5 JP2023530166 A5 JP 2023530166A5 JP 2022577618 A JP2022577618 A JP 2022577618A JP 2022577618 A JP2022577618 A JP 2022577618A JP 2023530166 A5 JP2023530166 A5 JP 2023530166A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- composition according
- topical composition
- fluticasone
- corticosteroid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201921053286 | 2020-06-15 | ||
| IN201921053286 | 2020-06-15 | ||
| PCT/IB2021/055222 WO2021255622A1 (en) | 2020-06-15 | 2021-06-14 | Combination of alcaftadine and a corticosteroid |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023530166A JP2023530166A (ja) | 2023-07-13 |
| JP2023530166A5 true JP2023530166A5 (enExample) | 2024-06-06 |
| JP7791119B2 JP7791119B2 (ja) | 2025-12-23 |
Family
ID=76523259
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022577618A Active JP7791119B2 (ja) | 2020-06-15 | 2021-06-14 | アルカフタジンとコルチコステロイドの組み合わせ |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230218630A1 (enExample) |
| EP (1) | EP4164614A1 (enExample) |
| JP (1) | JP7791119B2 (enExample) |
| KR (1) | KR20230024928A (enExample) |
| CN (1) | CN115701988A (enExample) |
| AU (1) | AU2021291684A1 (enExample) |
| BR (1) | BR112022024840A2 (enExample) |
| CA (1) | CA3181959A1 (enExample) |
| CL (1) | CL2022003534A1 (enExample) |
| MX (1) | MX2022015965A (enExample) |
| WO (1) | WO2021255622A1 (enExample) |
| ZA (1) | ZA202212128B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8580801B2 (en) | 2008-07-23 | 2013-11-12 | Robert I. Henkin | Phosphodiesterase inhibitor treatment |
| US10598672B2 (en) | 2014-02-18 | 2020-03-24 | Cyrano Therapeutics, Inc. | Methods and compositions for diagnosing and treating loss and/or distortion of taste or smell |
| WO2021194893A1 (en) | 2020-03-24 | 2021-09-30 | Cyrano Therapeutics, Inc. | Treatment of chemosensory dysfunction from a coronavirus infection |
| US20240173331A1 (en) | 2021-04-01 | 2024-05-30 | Alkem Laboratories Limited | Nasal compositions comprising alcaftadine |
| WO2023133460A1 (en) * | 2022-01-06 | 2023-07-13 | Cyrano Therapeutics, Inc. | Improved nasal administration of pharmaceutical formulations |
| WO2024228988A2 (en) * | 2023-05-02 | 2024-11-07 | Cyrano Therapeutics, Inc. | Treatment for taste and smell loss |
| GR1010821B (el) * | 2023-11-09 | 2024-11-15 | Ελπεν Α.Ε. Φαρμακευτικη Βιομηχανια, | Σταθερο ομογενοποιημενο φαρμακευτικο ρινικο εναιωρημα συνδυασμου αζελαστινης και φλουτικαζονης |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2053678T3 (es) | 1987-11-13 | 1994-08-01 | Asta Medica Ag | Procedimiento para preparar un medicamento con contenido de azelastina para la aplicacion nasal y/u ocular. |
| IL101850A (en) | 1991-06-13 | 1996-01-31 | Janssen Pharmaceutica Nv | 11-(4-Piperidinyl)-imidazo (2,1-b) (3) benzazepine derivatives their preparation and pharmaceutical compositions containing them |
| DE19947234A1 (de) * | 1999-09-30 | 2001-04-05 | Asta Medica Ag | Neue Kombination von Loteprednol und Antihistaminika |
| ES2258175T3 (es) * | 2001-12-05 | 2006-08-16 | Alcon, Inc. | Utilizacion de un antagonista de h1 y remixolona como esteroide inofensivo para el tratamiento de la rinitis. |
| BRPI0615032A2 (pt) | 2005-09-01 | 2011-04-26 | Biolipox Ab | composição farmacêutica, processo para a preparação da mesma, e, uso de uma composição |
| JP5292277B2 (ja) | 2006-03-31 | 2013-09-18 | ビスタコン・フアーマシユーチカルズ・エルエルシー | 眼アレルギーの処置 |
| US8569273B2 (en) * | 2009-03-17 | 2013-10-29 | Aciex Therapeutics, Inc. | Ophthalmic formulations of cetirizine and methods of use |
| WO2011141929A2 (en) * | 2010-05-11 | 2011-11-17 | Cadila Healthcare Limited | Aqueous pharmaceutical compositions of fluticasone and olopatadine |
| CN102283849A (zh) | 2011-06-29 | 2011-12-21 | 北京阜康仁生物制药科技有限公司 | 一种含有阿卡他定的药物组合物 |
| JP6294893B2 (ja) * | 2012-12-17 | 2018-03-14 | グラクソ グループ リミテッドＧｌａｘｏ Ｇｒｏｕｐ Ｌｉｍｉｔｅｄ | 炎症性及び／又はアレルギー性の状態を治療するためのレボカバスチンとフルチカゾンフランカルボン酸エステルとの併用 |
| MY191380A (en) * | 2013-09-13 | 2022-06-21 | Glenmark Specialty Sa | Stabilized fixed dose drug composition having mometasone and olopatadine |
| JP7191022B2 (ja) | 2017-07-28 | 2022-12-16 | 参天製薬株式会社 | アルカフタジン又はその塩を含有する水性医薬組成物 |
-
2021
- 2021-06-14 JP JP2022577618A patent/JP7791119B2/ja active Active
- 2021-06-14 AU AU2021291684A patent/AU2021291684A1/en active Pending
- 2021-06-14 MX MX2022015965A patent/MX2022015965A/es unknown
- 2021-06-14 US US17/997,656 patent/US20230218630A1/en active Pending
- 2021-06-14 KR KR1020227046470A patent/KR20230024928A/ko active Pending
- 2021-06-14 BR BR112022024840A patent/BR112022024840A2/pt unknown
- 2021-06-14 CN CN202180040805.7A patent/CN115701988A/zh active Pending
- 2021-06-14 CA CA3181959A patent/CA3181959A1/en active Pending
- 2021-06-14 EP EP21733564.5A patent/EP4164614A1/en active Pending
- 2021-06-14 WO PCT/IB2021/055222 patent/WO2021255622A1/en not_active Ceased
-
2022
- 2022-11-07 ZA ZA2022/12128A patent/ZA202212128B/en unknown
- 2022-12-12 CL CL2022003534A patent/CL2022003534A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Herman | Once-daily administration of intranasal corticosteroids for allergic rhinitis: a comparative review of efficacy, safety, patient preference, and cost | |
| HRP20200495T1 (hr) | Sastavi za liječenje gastrointestinalne upale | |
| RU2017142694A (ru) | Водная суспензия, содержащая наночастицы глюкокортикостероида | |
| HRP20140864T1 (hr) | Kombinacije koje sadrže antimuskarinska sredstva i beta-adrenergiäśke agoniste | |
| IL216932A (en) | Composition of pharmaceuticals containing azalastine and cyclozonide and method for the manufacture of a periodic allergy treatment containing this composition | |
| SI2393477T1 (en) | Use of a glucocorticoid composition for the treatment of severe and uncontrolled asthma | |
| JP2010540671A5 (enExample) | ||
| JP2011528355A (ja) | 充血除去剤およびコルチコステロイドを含む鼻腔内粗製物 | |
| JP2015506983A5 (enExample) | ||
| HRP20100104T1 (hr) | Kombinacije koje sadrže antimuskarinska sredstva i kortikosteroide | |
| WO2011141929A2 (en) | Aqueous pharmaceutical compositions of fluticasone and olopatadine | |
| US20090022671A1 (en) | Treatment methods | |
| JP4100713B2 (ja) | 鼻ポリープの治療におけるｈ▲上＋▼，ｋ▲上＋▼―ａｔｐアーゼ阻害剤の使用 | |
| JP2014526448A5 (enExample) | ||
| JP2006518382A5 (enExample) | ||
| Meltzer et al. | New intranasal formulations for the treatment of allergic rhinitis. | |
| Rohatagi et al. | Absolute oral versus inhaled bioavailability: significance for inhaled drugs with special reference to inhaled glucocorticoids | |
| US20070249572A1 (en) | Systems and methods for the delivery of corticosteroids | |
| WO2007075963A2 (en) | Systems and methods for the delivery of corticosteroids | |
| JP2014515360A (ja) | フルチカゾンを含む鼻用医薬製剤 | |
| US20070178050A1 (en) | Methods and systems for the delivery of corticosteroids having an increased lung depositon | |
| US20070197486A1 (en) | Methods and systems for the delivery of corticosteroids | |
| JP2011503109A5 (enExample) | ||
| US20070160542A1 (en) | Methods and systems for the delivery of corticosteroids having an enhanced pharmacokinetic profile | |
| US20070185066A1 (en) | Systems and methods for the delivery of corticosteroids |